1. Mutant p53 as a target for cancer treatment. (September 2017) Authors: Duffy, Michael J.; Synnott, Naoise C.; Crown, John Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007. (1st February 2018) Authors: Synnott, Naoise C.; Bauer, Matthias R.; Madden, Stephen; Murray, Alyson; Klinger, Rut; O'Donovan, Norma; O'Connor, Darran; Gallagher, William M.; Crown, John; Fersht, Alan R.; Duffy, Michael J. Journal: Cancer letters Issue: Volume 414(2018) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting p53 for the treatment of cancer. (February 2022) Authors: Duffy, Michael J.; Synnott, Naoise C.; O'Grady, Shane; Crown, John Journal: Seminars in cancer biology Issue: Volume 79(2022) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Vitamin D analogues: Potential use in cancer treatment. (April 2017) Authors: Duffy, Michael J.; Murray, Alyson; Synnott, Naoise C.; O'Donovan, Norma; Crown, John Journal: Critical reviews in oncology/hematology Issue: Volume 112(2017) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗